Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 8, 2011, Pages 431-437

  Ramaiah, K D ^a   Vanamail, P ^a   Yuvaraj, J ^b   Das, P K ^a  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Albendazole; Diethylcarbamazine; India; Lymphatic filariasis; Mass drug administration

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; PARASITE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BANCROFTIAN FILARIASIS; BLOOD SMEAR; CHILD; CIRCULATING FILARIAL ANTIGENEMIA; CLINICAL EFFECTIVENESS; CULEX QUINQUEFASCIATUS; DISEASE TRANSMISSION; DRUG ADMINISTRATION; HEALTH SURVEY; HUMAN; INDIA; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MASS DRUG ADMINISTRATION; MICROFILARIA; MICROFILARIASIS; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SINGLE DRUG DOSE; WUCHERERIA; WUCHERERIA BANCROFTI;

ALBENDAZOLE; ANIMALS; ANTIGENS, HELMINTH; CULEX; DIETHYLCARBAMAZINE; DRUG ADMINISTRATION SCHEDULE; ELEPHANTIASIS, FILARIAL; FEMALE; FILARICIDES; HUMANS; INDIA; MALE; MICROFILARIA; PREVALENCE; RURAL HEALTH; WUCHERERIA BANCROFTI;

EID: 79960331308     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.04.006     Document Type: Article

References (36)

1. Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec 2009; 84: 437-44.
2. Michael E., Bundy D.A.P. Global mapping of lymphatic filariasis. Parasitol Today 1997, 13:472-476.
3. Ramaiah K.D., Das P.K., Michael E., Guyatt H. The economic burden of lymphatic filariasis in India. Parasitol Today 2000, 16:251-253.
4. Ottesen E.A., Ramachandran C.P. Lymphatic filariasis infection and disease: control strategies. Parasitol Today 1995, 11:129-131.
5. Dreyer G., Addiss D., Aguiar A.M., Bettinger J., Dreyer P., Luiz A., et al. New hope - for people with lymphoedema 1999, US Centers for Disease Control and Prevention, Atlanta.
6. Weil G.J., Lammie P.J., Weiis N. The ICT filariasis test: a rapid format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 1997, 13:401-404.
7. Ottesen E.A. The global programme to eliminate lymphatic filariasis. Trop Med Int Health 2000, 5:591-594.
8. Das P.K., Ramaiah K.D., Vanamail P., Pani S.P., Yuvaraj J., Balarajan K., et al. Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India. Trans R Soc Trop Med Hyg 2001, 95:336-341.
9. Ramaiah K.D., Das P.K., Vanamail P., Pani S.P. The impact of six rounds of single dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination. Trop Med Int Health 2003, 8:1082-1092.
10. Ramaiah K.D., Das P.K. Seasonality of adult Culex quinquefasciatus and transmission of bancroftian filariasis in Pondicherry, South India. Acta Trop 1992, 50:275-283.
11. Rajendran R., Sunish I.P., Mani T.R., Munirathnam A., Arunachalam N., Satyanarayana K., et al. Community based study to assess the efficacy of DEC plus albendazole against DEC alone on bancroftian filariasis infection in endemic areas in Tamil Nadu, south India. Trop Med Int Health 2006, 11:851-861.
12. Mani T.R., Rajendran R., Sunish I.P., Munirathnam A., Arunachalam N., Satyanarayana K., et al. Effectiveness of two annual single dose mass drug administration of diethylcarbamazine alone or in combination with albendazole on soil transmitted helminthiasis in filariasis elimination programme. Trop Med Int Health 2004, 9:1030-1035.
13. Ramaiah K.D., Das P.K., Appavoo N.C., Ramu K., Augustin D.J., Vijay Kumar K.N., et al. A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single dose DEC mass treatment and some related operational aspects. Trop Med Int Health 2000, 5:842-847.
14. Babu B.V., Satyanarayana K. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India. Trop Doc 2003, 33:79-82.
15. Weerasooriya M.V., Yahathugoda C.T., Wickramasinghe D., Gunawardena K.N., Dharmadasa R.A., Vidanapathirana K.K., et al. Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) programme for the elimination of lymphatic filariasis in Sri Lanka. Filaria J 2007, 6:11. 10.1186/1475-2883-6-11.
16. Lahariya C., Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. J Vector Borne Dis 2008, 45:313-320.
17. WHO. Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. Geneva: World Health Organization; 2005. WHO/CDS/CPE/CEE 2005.50.
18. Bonfim C., Netto M.J.E., Pedroza D., Portugal J.L., Medeiros Z. A socio-environmental composite index as a tool for identifying urban areas at risk of lymphatic filariasis. Trop Med Int Health 2009, 8:877-884.
19. Lowrie R.C., Eberhard M.L., Lammie P.J., Raccurt C.P., Katz S.P., Duverseau Y.T. Uptake and development of Wuchereria bancrofti in Culex quinquefasciatus that fed on Haitian carriers with different microfilaria densities. Am J Trop Med Hyg 1989, 41:429-435.
20. Gad A.M., Hammad R.E., Farid H.A. Uptake and development of Wuchereria bancrofti in Culex pipiens L. and Aedes caspius Pallas. J Egypt Soc Parasitol 1996, 26:305-314.
21. Britto A.C., Fontes G., Williams P., Rocha E.M.M. Bancroftian filariasis in Maceio state of Alagoas Brazil: observations on Culex quinquefasciatus after blood feeding on individuals with different densities of microfilariae in the peripheral blood stream. Am J Trop Med Hyg 1998, 58:489-494.
22. Hammad R.E., Morsy Z.S., Farid H.A. Relationship between Culex pipiens infection with Wuchereria bancrofti and microfilarial levels in human blood. J Union Arab Biol 1998, 9:441-453.
23. Jayasekera N., Kalpage K.S., De Silva C.S. The significance of low density microfilaraemia in the transmission of Wuchereria bancrofti by Culex (Culex) quinquefasciatus Say in Sri Lanka. Trans R Soc Trop Med Hyg 1991, 85:250-254.
24. Cui Z.H., Shang Q., Yang B.J., Lin X.J., Xu J.F., Gao C.L., et al. Epidemiological surveillance of filariasis after its being basically eradicated in Shandong Province [in Chinese]. Chung Kuo Chi Sheng Chung Hsueh Yu Chi Sheng Chung Ping Tsa Chih 1989, 7:4-7.
25. Farid A.H., Hammad R.E., Soliman D.A., El Setouhy M.A., Ramzy R.M.R., Weil G.J. Relationships between Wuchereria bancrofti microfilaria counts in human blood and parasite uptake and maturation in Culex pipiens with observations on the effects of diethylcarbamazine treatment on these parameters. Am J Trop Med Hyg 2003, 68:286-293.
26. Farid H.A., Hammad R.E., Hassan M.M., Ramzy R.M.R., El Setouhy M., Weil G.J. Effects of combined diethylcarbamazine and albendazole treatment of bancroftian filariasis on parasite uptake and development in Culex pipiens L. Am J Trop Med Hyg 2005, 73:108-114.
27. Richards F.O., Pam D.D., Kal A., Gerlong G.Y., Onyeka J., Sambo Y., et al. Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual ivermectin-based mass treatments in Nigeria. Ann Trop Med Parasitol 2005, 99:155-164.
28. Hairston N.G., de Meillon B. On the inefficiency of transmission of Wuchereria bancrofti from mosquito to human host. Bull World Health Organ 1968, 38:935-941.
29. Grady C.A., de Rochars M.B., Direny A.N., Orelus J.N., Wendt J., Radday J., et al. Endpoints for lymphatic filariasis programs. Emerg Infect Dis 2007, 13:608-610.
30. Ramaiah K.D., Vanamail P., Das P.K. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine. Trans R Soc Trop Med Hyg 2007, 101:250-255.
31. Ramzy R.M.R., El Setouhy M., Helmy H., Ahmed E.S., Abd Elaziz K.M., Farid H.A., et al. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 2006, 367:992-999.
32. Ramaiah K.D., Thiruvengadam B., Vanamail P., Subramanian S., Gunasekaran S., Nilamani N., et al. Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme. Trop Med Int Health 2009, 14:870-876.
33. Xu B., Cui X., Zhang Y., Chang J., Zhao Q., Huang Q., et al. Studies on the transmission potential of filariasis in controlled areas of Henan province. Chin Med J (Engl) 1997, 110:807-810.
34. Michael E., Malecela-Lazaro M.N., Kabali C., Snow L.C., Kazura J.W. Mathematical models and lymphatic filariasis control: end points and optimal interventions. Trends Parasitol 2006, 22:226-233.
35. Vijay Kumar K.N., Ramaiah K.D. Usage of personal protection measures against mosquitoes and the low prevalence of Wuchereria bancrofti microfilaraemia in the Indian city of Chennai. Ann Trop Med Parasitol 2008, 102:391-397.
36. Njenga S.M., Wamae C.N., Njomo D.W., Mwandawiro C.S., Molyneux D.H. Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi Kenya. Trans R Soc Trop Med Hyg 2008, 102:1017-1024.